We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Paxlovid

News List

Pfizer seeks EUA for Covid-19 antiviral pill in US Pharmaceutical-Business-Review
November 18, 2021
Pfizer has submitted an application to the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of its investigational oral antiviral drug, Paxlovid (PF-07321332; ritonavir).
Pfizer seeks FDA EUA for oral antiviral pill to treat Covid-19 Pharmaceutical-Technology
November 18, 2021
Pfizer has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its experimental oral antiviral pill, Paxlovid (PF-07321332; ritonavir), to treat individuals with mild-to-moderate Covid-19.
Oral antiviral candidate Paxlovid™ reduces COVID-19 risks by 89 percent EuropeanPharmaceuticalReview
November 09, 2021
Pfizer has announced its investigational novel COVID-19 oral antiviral candidate, Paxlovid™, significantly reduced hospitalisation and death, based on an interim analysis of the Phase II/III EPIC-HR randomised...

Previous page 1 2 3 4 Next page